Martha Geoffrey
Officer, Director at MDT
- Sold, on record
- $12.2M
- Dollars the filings state
- Form 4 sales
- 7
- Latest Jun 7, 2024
- Form 144 notices
- 1
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- MDTMedtronic plcOfficer, Director
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale MDTPlan not statedJul 15, 2016 2016
Sold 3,766 shares at $88.26 ($332k)
Martha Geoffrey, EVP & GroupPres Restora Therap
Sold 12.5% of holdings ($2.7M position)26,273 shares leftFirst sale on recordFiling
- 2 Form 4 sale MDTUnusualSep 24, 2018 +801 days
Sold 49,799 shares at $97.93 ($4.9M)
Martha Geoffrey, EVP & GroupPres Restora Therap
Sold 45.7% of holdings ($10.7M position)59,202 shares leftFirst sale on recordFiling
- 3 Form 4 sale MDTPlan not statedJun 6, 2019 +255 days
Sold 11,000 shares at $96.05 ($1.1M)
Martha Geoffrey, EVP & GroupPres Restora Therap
Sold 18.4% of holdings ($5.8M position)48,918 shares leftFiling
- 4 Form 4 sale MDTPlan not statedApr 5, 2021 +669 days
Sold 11,712 shares at $118.83 ($1.4M)
Martha Geoffrey, CEO
Sold 12.5% of holdings ($11.1M position)81,938 shares leftFiling
- 5 Form 4 sale MDTPlan not statedJun 28, 2021 +84 days
Sold 11,500 shares at $125.29 ($1.4M)
Martha Geoffrey, CEO
Sold 12.3% of holdings ($11.7M position)81,948 shares leftFiling
- 6 Form 4 sale MDTPlan not statedAug 25, 2021 +58 days
Sold 11,581 shares at $132.67 ($1.5M)
Martha Geoffrey, CEO
Sold 10.8% of holdings ($14.3M position)95,836 shares leftFiling
- 7 Form 144 notice MDTNoticeJun 7, 2024 +1017 days
Filed to sell 19,113 shares ($1.6M)
Martha Geoffrey, Officer, Director
No 10b5-1 planFirst sale on recordFiling
- 8 Form 4 sale MDTNo planJun 7, 2024 same day
Sold 19,113 shares at $83.77 ($1.6M)
Martha Geoffrey, Chairman and CEO
No 10b5-1 planSold 11.8% of holdings ($13.6M position)143,348 shares leftFirst sale on recordFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (8)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jun 7, 2024 | Jun 11, 2024 | MDT | Chairman and CEO | Form 4 sale | 19,113 | $1.6M | 11.8% | No plan | SEC |
| Jun 7, 2024 | Jun 7, 2024 | MDT | Officer, Director | Form 144 notice | 19,113 | $1.6M | Notice | SEC | |
| Aug 25, 2021 | Aug 26, 2021 | MDT | CEO | Form 4 sale | 11,581 | $1.5M | 10.8% | Plan not stated | SEC |
| Jun 28, 2021 | Jun 30, 2021 | MDT | CEO | Form 4 sale | 11,500 | $1.4M | 12.3% | Plan not stated | SEC |
| Apr 5, 2021 | Apr 7, 2021 | MDT | CEO | Form 4 sale | 11,712 | $1.4M | 12.5% | Plan not stated | SEC |
| Jun 6, 2019 | Jun 7, 2019 | MDT | EVP & GroupPres Restora Therap | Form 4 sale | 11,000 | $1.1M | 18.4% | Plan not stated | SEC |
| Sep 24, 2018 | Sep 25, 2018 | MDT | EVP & GroupPres Restora Therap | Form 4 sale | 49,799 | $4.9M | 45.7% | Unusual | SEC |
| Jul 15, 2016 | Jul 19, 2016 | MDT | EVP & GroupPres Restora Therap | Form 4 sale | 3,766 | $332k | 12.5% | Plan not stated | SEC |